178 related articles for article (PubMed ID: 29293881)
1. Prognostic markers for colorectal cancer: estimating ploidy and stroma.
Danielsen HE; Hveem TS; Domingo E; Pradhan M; Kleppe A; Syvertsen RA; Kostolomov I; Nesheim JA; Askautrud HA; Nesbakken A; Lothe RA; Svindland A; Shepherd N; Novelli M; Johnstone E; Tomlinson I; Kerr R; Kerr DJ
Ann Oncol; 2018 Mar; 29(3):616-623. PubMed ID: 29293881
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer.
Ersvaer E; Hveem TS; Vlatkovic L; Brennhovd B; Kleppe A; Tobin KAR; Pradhan M; Cyll K; Waehre H; Kerr DJ; Danielsen HE
Int J Cancer; 2020 Aug; 147(4):1228-1234. PubMed ID: 31846064
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral stromal morphometry predicts disease recurrence but not response to 5-fluorouracil-results from the QUASAR trial of colorectal cancer.
Hutchins GGA; Treanor D; Wright A; Handley K; Magill L; Tinkler-Hundal E; Southward K; Seymour M; Kerr D; Gray R; Quirke P;
Histopathology; 2018 Feb; 72(3):391-404. PubMed ID: 28746977
[TBL] [Abstract][Full Text] [Related]
5. Automated assessment of CD8
Jiang D; Hveem TS; Glaire M; Church DN; Kerr DJ; Yang L; Danielsen HE
EBioMedicine; 2021 Sep; 71():103547. PubMed ID: 34479131
[TBL] [Abstract][Full Text] [Related]
6. Chromatin organisation and cancer prognosis: a pan-cancer study.
Kleppe A; Albregtsen F; Vlatkovic L; Pradhan M; Nielsen B; Hveem TS; Askautrud HA; Kristensen GB; Nesbakken A; Trovik J; Wæhre H; Tomlinson I; Shepherd NA; Novelli M; Kerr DJ; Danielsen HE
Lancet Oncol; 2018 Mar; 19(3):356-369. PubMed ID: 29402700
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
Li Y; Liao L; Kong L; Jiang W; Tang J; Han K; Hou Z; Zhang C; Zhou C; Zhang L; Sui Q; Xiao B; Mei W; Xu Y; Yu J; Hong Z; Pan Z; Ding P
Clin Transl Oncol; 2023 Jan; 25(1):218-225. PubMed ID: 36076121
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer.
Yang L; Chen P; Zhang L; Wang L; Sun T; Zhou L; Li Z; Wu A
Br J Cancer; 2020 Sep; 123(6):973-981. PubMed ID: 32624576
[TBL] [Abstract][Full Text] [Related]
9. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.
Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY
Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content - a short report.
Sandberg TP; Sweere I; van Pelt GW; Putter H; Vermeulen L; Kuppen PJ; Tollenaar RAEM; Mesker WE
Cell Oncol (Dordr); 2019 Jun; 42(3):397-403. PubMed ID: 30847807
[TBL] [Abstract][Full Text] [Related]
11. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of ploidy of primary tumour and nodal secondaries in colorectal cancers.
Zoras OI; Curti G; Cooke TG; Vlachonikolis IG; Forster G; McArdle CS; Stanton PD
Surg Oncol; 1994 Dec; 3(6):345-9. PubMed ID: 7773451
[TBL] [Abstract][Full Text] [Related]
14. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer.
Peng J; Li W; Fan W; Zhang R; Li X; Xiao B; Dong Y; Wan D; Pan Z; Lin J; Wu X
Cancer Cell Int; 2021 Oct; 21(1):554. PubMed ID: 34688293
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
[TBL] [Abstract][Full Text] [Related]
17. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
18. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.
Skrede OJ; De Raedt S; Kleppe A; Hveem TS; Liestøl K; Maddison J; Askautrud HA; Pradhan M; Nesheim JA; Albregtsen F; Farstad IN; Domingo E; Church DN; Nesbakken A; Shepherd NA; Tomlinson I; Kerr R; Novelli M; Kerr DJ; Danielsen HE
Lancet; 2020 Feb; 395(10221):350-360. PubMed ID: 32007170
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
